THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS
Author:
- Ivan StockleyISIvan Stockley
- 1 December 1980
- journal article
- research article
- Published by Walter de Gruyter GmbH in Drug Metabolism and Drug Interactions
- Vol. 3 (1-2) , 1-30
Abstract
Article THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS was published on December 1, 1980 in the journal Drug Metabolism and Personalized Therapy (volume 3, issue 1-2).Keywords
This publication has 38 references indexed in Scilit:
- Pethidine interaction with clorgyline, pargyline, or 5-hydroxytryptophan: lack of enhanced pethidine lethality or hyperpyrexia in miceJournal of Pharmacy and Pharmacology, 1978
- Unplanned pregnancy in an epileptic.BMJ, 1972
- Drug enzyme induction and drug interactions: Literature tabulationToxicology and Applied Pharmacology, 1971
- Interaction of environmental agents and drugsEnvironmental Research, 1969
- APPARENT RESISTANCE TO ORAL ANTICOAGULANT THERAPY AND INFLUENCE OF HYPNOTICS ON SOME COAGULATION FACTORSActa Medica Scandinavica, 1968
- Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure.BMJ, 1967
- Metabolic and therapeutic effects of allopurinol in patients with leukemia and goutThe American Journal of Medicine, 1966
- Inhibition of dopamine- β -hydroxylase by disulfiramLife Sciences, 1964
- INTERACTION BETWEEN CHEESE AND MONOAMINE-OXIDASE INHIBITORS IN RATS AND CATSThe Lancet, 1964
- THE IN VIVO POTENTIATION OF BARBITURATES BY TETRAETHYLTHIURAM DISULPHIDEJournal of Pharmacy and Pharmacology, 1951